CATALOGO DEI PRODOTTI DELLA RICERCA

Maggino, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.638
EU - Europa 1.538
AS - Asia 675
AF - Africa 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 3.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.635
CN - Cina 542
GB - Regno Unito 454
IT - Italia 186
IE - Irlanda 185
FR - Francia 176
SE - Svezia 159
RU - Federazione Russa 141
DE - Germania 110
SG - Singapore 86
FI - Finlandia 50
UA - Ucraina 38
JP - Giappone 27
BE - Belgio 13
IN - India 5
DZ - Algeria 4
KR - Corea 4
NL - Olanda 4
BR - Brasile 3
CZ - Repubblica Ceca 3
EU - Europa 3
GR - Grecia 3
AU - Australia 2
CA - Canada 2
DK - Danimarca 2
IR - Iran 2
KG - Kirghizistan 2
LV - Lettonia 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
KH - Cambogia 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
TW - Taiwan 1
Totale 3.869
Salva come PNG Salva come JPEG
Città #
Southend 438
Chandler 418
Dublin 181
Jacksonville 153
Ashburn 126
Beijing 125
Woodbridge 111
Verona 68
Lawrence 65
Princeton 65
Jinan 55
Houston 54
Redmond 49
Singapore 47
Wilmington 45
Nanjing 43
Shenyang 39
Helsinki 29
New York 25
Ann Arbor 24
Haikou 24
Redwood City 23
Tianjin 23
Changsha 19
Hebei 19
Ningbo 19
Sindelfingen 19
Hangzhou 18
Tokyo 18
Nanchang 17
Seattle 14
Washington 14
Brussels 13
Fairfield 12
Zhengzhou 12
Norwalk 11
Taiyuan 11
Taizhou 11
Fuzhou 9
Lancaster 9
Milan 9
Falkenstein 8
Falls Church 8
Lappeenranta 7
Dongguan 6
Jiaxing 6
Pignone 6
Dallas 5
Düsseldorf 5
Guangzhou 5
Hyderabad 5
Kent 5
Los Angeles 5
San Francisco 5
Bologna 4
Cagliari 4
Dearborn 4
Des Moines 4
Minoh 4
Seoul 4
Algiers 3
Brno 3
Chicago 3
Lanzhou 3
Leawood 3
Pawtucket 3
Pozzo Di Gotto 3
Riva 3
Amsterdam 2
Athens 2
Bishkek 2
Catania 2
Curitiba 2
Fabriano 2
Groningen 2
Iglesias 2
Ivrea 2
Lana 2
Mehlingen 2
Moscow 2
Pomezia 2
Toronto 2
Yicheng 2
Baku 1
Battipaglia 1
Bergen 1
Boardman 1
Bolzano 1
Bratislava 1
Brierley Hill 1
Budapest 1
Cairo 1
Cambridge 1
Chisinau 1
Cleveland 1
Clifton 1
Copenhagen 1
Cupertino 1
Eden Prairie 1
Fremont 1
Totale 2.655
Salva come PNG Salva come JPEG
Nome #
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 113
Results of a surveillance protocol for pancreatic BD-IPMNs 109
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 105
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 102
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 101
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 99
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 89
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 88
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 87
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 84
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer 83
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 83
Assessment of a complication risk score and study of complication profile in laparoscopic distal pancreatectomy 82
Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer 82
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 82
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 81
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 79
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group 74
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) 73
An unforeseeable adverse event during ERCP 72
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 67
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC) An International Delphi Study Among Patients and Health Care Providers 64
Pancreatic Adenocarcinoma 63
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 63
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 60
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 59
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 59
Assessing the influence of experience in pancreatic surgery: a risk-adjusted analysis using the American College of Surgeons NSQIP database 59
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 57
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 56
Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy 51
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 51
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer 49
Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? 48
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? 47
Intraductal Papillary Mucinous Neoplasm Around the World 46
Defining the practice of distal pancreatectomy around the world 46
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 46
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies 45
Trends in practice patterns and outcomes: A decade of sarcoma care in the United States 45
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 45
The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy 44
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation 43
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis 43
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia 43
Response to: Managing the High-risk Pancreatic Anastomosis 41
Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis 41
Surgical experience and the practice of pancreatoduodenectomy 40
Response to Comment on "Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma" 40
Extended Experience with a Dynamic, Data-Driven Selective Drain Management Protocol in Pancreaticoduodenectomy: Progressive Risk Stratification for Better Practice 40
ASO Author Reflection: Location of Nodal Metastases in Pancreatoduodenectomy for Cancer: Which Station Matters? 39
Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database 37
Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis 36
Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer 36
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 35
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 33
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma 32
Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma 31
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 29
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 29
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 29
Response to: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation" 29
Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm? 29
Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes 29
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 29
Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol 29
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 28
Forecasting surgical costs: Towards informed financial consent and financial risk reduction 27
Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score 26
Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution? 26
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 21
The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy 19
The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy 17
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 16
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review 10
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 9
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review 7
Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study 7
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis 6
Totale 3.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.142
article - articoli 16.566
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 354
patent - brevetti 0
selected - selezionate 0
volume - volumi 222
Totale 34.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020368 0 0 5 8 119 69 41 6 9 27 24 60
2020/2021548 89 85 19 86 62 83 29 5 13 16 44 17
2021/2022459 45 120 10 24 10 10 12 33 29 16 32 118
2022/20231.168 71 139 102 195 100 300 30 79 106 11 22 13
2023/2024639 26 64 64 65 67 115 54 42 14 18 79 31
2024/2025187 81 90 16 0 0 0 0 0 0 0 0 0
Totale 3.999